We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New research at the University of East Anglia (UEA), UK has highlighted the need for changes to the system where pharmaceutical companies forge deals with competitors to prevent the production of generic medicines.